Chemed (CHE) Q2 2026 earnings review
VITAS Roars Back, Driving Massive Guidance Hike
Chemed delivered an exceptionally strong second quarter, driven entirely by a spectacular turnaround at its VITAS healthcare segment. Consolidated revenue accelerated to 8.8% YoY growth ($673.3M), while Adjusted EPS surged 41.9% to $6.06. The ghost of 2025's Florida Medicare Cap disaster has been completely exorcised, with VITAS margins expanding dramatically. While Roto-Rooter remains sluggish and margin-constrained due to structural marketing costs, the sheer cash-generation power of a normalized VITAS allowed management to aggressively buy back stock and materially raise full-year EPS guidance.
🐂 Bull Case
The patient mix rebalancing strategy has worked flawlessly. Admissions grew 9.0% and Average Daily Census (ADC) grew 6.1%, driving an explosive 60.5% increase in VITAS net income. The Florida Cap headwind is officially zero.
Management retired a staggering 10.5% of the company's outstanding shares over the trailing 12 months, supercharging EPS growth and demonstrating immense confidence in the cash flow profile.
🐻 Bear Case
Roto-Rooter Adjusted EBITDA margin contracted another 77 basis points YoY to 21.1%. The forced shift from organic Google search to expensive paid leads appears to be a permanent impairment to legacy margin targets.
Roto-Rooter's core residential water restoration segment remains broken, falling 6.7% YoY in Q2, dragging down an otherwise modest residential recovery.
⚖️ Verdict: 🟢
Bullish. The Roto-Rooter issues are annoying but quarantined. The sheer magnitude of the VITAS recovery—evidenced by raising segment margin guidance a full 100 bps mid-year—overshadows the plumbing segment's growing pains.
Key Themes
VITAS Profitability Eruption
Reversing the painful trends of 2025, VITAS Adjusted EBITDA (excluding Medicare Cap) surged 20.6% YoY to $80.6 million. The margin expanded by an incredible 196 basis points to 18.2%. This was driven by a 6.1% increase in days-of-care and a 2.4% Medicare reimbursement rate increase, completely overriding a 115-basis point headwind from acuity mix shift.
Unrelenting Share Repurchases
Chemed is leveraging its pristine balance sheet to engineer massive EPS growth. The company spent $89.8 million in Q2 to repurchase 210,000 shares at $427.81. Over the last 12 months, they have retired 1.51 million shares—10.5% of the entire company—at an average price of $423.63. This financial engineering effectively turns high-single-digit revenue growth into 40%+ EPS growth.
Roto-Rooter Commercial Segment Rebounds
While residential plumbing struggles, Roto-Rooter's Commercial segment acted as a vital stabilizer, accelerating to 6.8% YoY growth ($56.8M). This was led by a massive 11.9% jump in commercial plumbing and a 6.9% increase in commercial drain cleaning, reflecting the success of the expanded commercial sales force initiated in late 2025.
Google Algorithm Shift Permanently Impairs Margins
Roto-Rooter's Adjusted EBITDA margin shrank by 77 basis points to 21.1%, despite flat absolute EBITDA ($48.5M). The core culprit remains a technological shift: Google's algorithm changes have killed 'free' organic search visibility, forcing Chemed into a permanent reliance on expensive paid search marketing to generate leads. SG&A at Roto-Rooter spiked 11.3% YoY, vastly outpacing the segment's 3.3% revenue growth.
Independent Contractors Segment Bleeding
Roto-Rooter's Independent Contractors segment continues to be a persistent laggard, decelerating further with a 1.9% revenue decline to $17.1 million. While a smaller part of the pie, this cohort is clearly struggling to adapt to the higher customer acquisition costs in the modern digital marketing environment.
Water Restoration Business Remains Broken
Despite management's 2025 initiative to centralize billing to combat aggressive insurance write-offs, Roto-Rooter's residential water restoration revenue dropped another 6.7% YoY. This contradicts the positive narrative from early 2026 that centralization was stabilizing the segment.
Macro Pressures on Residential Services
Broader macroeconomic uncertainty and tighter consumer wallets continue to put a ceiling on Roto-Rooter's residential volume. Core residential drain cleaning eked out a meager 1.3% growth, indicating that absent emergency necessity, homeowners are delaying discretionary plumbing maintenance.
Other KPIs
The balance sheet was restructured in April 2026 with a new $450 million credit facility (plus $250M accordion). Debt sits at a highly manageable $140 million against trailing twelve-month Adjusted EBITDA of over $240 million. This leaves immense dry powder ($262.7M undrawn) for further M&A or buybacks.
Accelerating improvement. This compares to a devastating $16.4 million accrual in Q2 2025. Crucially, zero dollars were accrued for the problematic Florida combined program, validating management's aggressive pivot toward short-stay hospital admissions initiated last year.
Guidance
Accelerating. Raised significantly from the Q1 estimate of $24.00 to $24.75. The $25.37 midpoint implies a 17.8% YoY increase from 2025's $21.55. This massive bump is driven primarily by outperformance in the VITAS segment and the mathematically accretive nature of the heavy Q2 share buybacks.
Accelerating. Raised from 6.5% - 7.5%. This is a massive vote of confidence, driven by a higher-than-expected Average Daily Census (ADC) growth target, which was also raised 125 basis points to a midpoint of 6.0%.
Accelerating. Raised a full 100 basis points from the prior 18.0% - 18.5% range. The scale of this revision mid-year suggests labor efficiencies and admission mix are tracking substantially ahead of internal models.
Stable. Unchanged from Q1. This implies a continuation of the sluggish, low-single-digit trajectory, relying heavily on commercial strength to offset residential macro headwinds.
Stable. Unchanged from Q1's downward revision. Management has effectively conceded that the structural shift in Google lead generation costs has permanently recalibrated the segment's margin profile downward from historical 24-25% highs.
Key Questions
VITAS Margin Ceiling
You raised the full-year VITAS margin target by a full 100 basis points. Given the historic volatility surrounding the Medicare Cap, how much of this margin expansion is structural versus a temporary benefit from over-correcting your length-of-stay mix?
Roto-Rooter Residential Water Restoration
Despite centralizing the billing process last year to combat insurance write-offs, residential water restoration revenues dropped another 6.7% this quarter. Is this a volume issue, a pricing issue, or are insurance carriers still squeezing the realization rate?
Capital Allocation Priority
You've retired 10.5% of the float in just 12 months. With the new $450M credit facility in place, do you intend to maintain this aggressive pace of repurchases, or are there actionable, large-scale franchise acquisitions on the horizon for Roto-Rooter?